Go to deals
Healthcare

Sopharma Group has acquired two pharmaceutical products in Poland

Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.

Sopharma Group is a leading producer and distributor of healthcare products in the CEE, with a vertically integrated business model running through the whole value chain, with its own R&D, manufacturing and wholesale and retail distribution. The company is present in 33 countries and has a portfolio consisting of more than 200 products.

Coffepirine and Kopiryna are OTC analgesics with APIs based on a combination of acetylsalicylic acid and caffeine, which have helped the Polish public to treat headaches for decades. The drugs are developed and manufactured by Medicofarma, a well-known Polish pharmaceuticals company.

Medicofarma is a pharmaceutical manufacturing company focusing on contract manufacturing of pharmaceuticals, medicinal products and dietary supplements. The company has a modern factory equipped with state-of-the-art technology and meets all GMP requirements.

Oaklins’ team in Bulgaria acted as buy-side advisor to Sopharma Group, leading the transaction process, deal structuring and negotiations, and assisting throughout the acquisition process.

Parties

Talk to the deal team

 Ivan  Angelov

Ivan Angelov

Associate Director
Sofia, Bulgaria
Oaklins Karoll
 Nasko  Jordanov

Nasko Jordanov

Principal
Sofia, Bulgaria
Oaklins Karoll

Related deals

Prestige Inhome Care has found a long-term strategic partner
Healthcare

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more
Apotheka acquires two pharmacy outlets from Panpharmacy
Consumer & Retail | Healthcare

Apotheka acquires two pharmacy outlets from Panpharmacy

In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.

Learn more